These results indicated that CD36 genetic variants mainly affect the circulating lipid profile through the regulation of TC and HDL-C, and the T2DM subjects with CD36 rs1049673, rs1054516, and rs2151916 genetic variants are prone to have dyslipidemia. Here, CD36 is linked to type 2 diabetes mellitus.